The Importance of Trials in Chemotherapy

Pembrolysmab is our most active second line agent, a regimen. Our other options are re treatment with carboplatin pectylataxal carboplatin bicarbonate of soda or Taxane. We need we need better things and I think that's what Dr. Monks just about to tell us. And you have my commitment as co director of the GOG by the end of the year to have a randomized phase three trial in all comer population of a novel agent in the second line. It has an A sign name three zero nine some Merck name 775. But these second MSI both which led to Pembrolym were transformational